The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

15 Dec 2016 07:00

RNS Number : 9005R
Falanx Group Limited
15 December 2016
 

Falanx Group Limited

("Falanx" or "the Company")

 

ANNUAL GENERAL MEETING STATEMENT AND TRADING UPDATE

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to provide an update on its current trading, ahead of the Company's Annual General Meeting, which will be held today at 10:00am at the offices of DWF LLP at 31st Floor, 20 Fenchurch Street, London EC3M 3AGr.

 

Trading Update

 

The Company is pleased to announce further progress in its third quarter, in line with the guidance given in its interim results released on 1 November 2016, with highlights as follows:

 

· Falanx Cyber Defence has secured its first FTSE100 Banking and Retail Financial Services client. Initial revenue of £0.4m is expected to be generated in the current financial year.

· Falanx Intelligence has additional contracts to provide embedded expertise and increased services to a FTSE100 Telecoms Major and a FTSE100 Audit and Consultancy organisation, generating £0.24m and £0.23m respectively in this financial year.

· Focus on the Financial Services sector is proving successful, with a total of £1.25m of revenue being generated in this financial year by the provision of Intelligence and Cyber Defence services to a wide range of Banking, Fund Management, Trading and Financial Support services.

· On track for planned organic growth in H2, with significant staff hiring programme.

· Sufficient cash to fund H2 organic needs on a debt free basis.

 

The above described contracts, together with an ongoing focus on the Financial Services sector, have contributed to a good financial performance by the Company in the third quarter. It is clear that cyber-security and hacking is only increasing as an issue, not just for larger firms, but also for mid-sized firms who are handling sensitive transactions and significant sums of capital, but often unable to fund enlarged security teams within their smaller operational budgets. These firms are now looking to buy in their cyber defense and intelligence as a managed service and this mid-market is maturing quickly as a result.

 

Outlook

Falanx continues to make considerable progress in 2016, both in terms of its financial performance, contract wins and the strengthening of our senior executive team. We are engaged in a significant recruitment push across the business, which will, in turn, underpin our continued drive to positive cash flow from operations next year. As a consequence of the quality of our people and our offering, and the continued growth of the markets in which Falanx operates, we look forward to reporting full-year revenue in line with our expectations and, with considerable confidence, to 2017.

 

A downloadable copy of the CEO's presentation for the 2016 AGM can be found at;

 

http://www.falanxgroup.com/aim-rule-26/announcements/

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive

 

 

 

via Walbrook PR

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

Panmure Gordon (UK) Limited

Nominated Adviser & Joint Broker

Andrew Godber / Peter Steel

 

+44 (0) 20 7886 2500

Whitman Howard Limited

Joint Broker

Nick Lovering / Francis North

 

+44 (0) 207 659 1234

Walbrook PR (Media and Investor Relations) Paul Cornelius / Nick Rome

+44 (0) 207 933 8780

falanx@walbrookpr.com

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFFESFIFMSEEE
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.